Wave Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investors conferences in May.
RBC Capital Markets 2022 Global Healthcare Conference (New York, NY)
H.C. Wainwright Global Investment Conference (Miami, FL)
Live webcasts of these presentations will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifescinces.com. Replays of these presentations will be archived and available on the site for a limited time following the event.
About Wave Life Sciences
Keynote Presentation - Open to all Badge Holders
Lunch Vouchers Provided to Paid Conference Pass Holders, Exhibitors, Sponsors, Speakers, Press
Presentation Details TBA